 Connection
Yong-Chen Lu to Tumor Microenvironment
This is a "connection" page, showing publications Yong-Chen Lu has written about Tumor Microenvironment.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.254 |
|
|
|
-
Cron KR, Fang P, Pham O, Janes J, Brandenburg J, Lu W, Zhu J, Peterson B, Tribble S, Kehoe H, Makarova A, Iannello A, Chan J, Skoble J, He H, Rae C, Thanos CD, Udyavar AR. ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Ra and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune response. Oncotarget. 2025 Oct 06; 16:721-740.
Score: 0.204
-
Maravelia P, Yao H, Cai C, Nascimento Silva D, Fransson J, Nilsson OB, Lu YW, Micke P, Botling J, Gatto F, Rovesti G, Carlsten M, Sallberg M, St?l P, Jorns C, Buggert M, Pasetto A. Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation. Gut. 2025 Jun 06; 74(7):1125-1136.
Score: 0.050
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|